Work

Can OS-6 replace PFS-6 as a primary endpoint in phase II studies on glioblastoma patients given antiangiogenetic drugs?

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.2022

Authors: E. Franceschi, A. A. Brandes, A. Tosoni, A. Bacci, L. Morandi, F. Spagnolli, R. Degli Esposti, S. Bartolini, R. Poggi, M. Ermani

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2523965286

Cites:

Cited by: 4

Related to: 10